How AI-powered Precision4Me tool is improving early cancer screenings
Other content in this Stream
Providence Montana - HealthBreak - Prevention4Me - Genetic Cancers
Prevention4Me - Genetic Cancers Providence is helping women proactively manage their cancer risk by participating in the Prevention4Me program.
New Lifeline for Patients with Acute Liver Failure
Longitudinal multiomics profiling of extracorporeal cross-circulation with pig liver xenografts in human decedents
Early Diagnosis and Precision Genomics Help Reverse a Rare, Life-Threatening Cancer Complication
Early Diagnosis and Precision Genomics Help Reverse a Rare, Life-Threatening Cancer Complication
New Discovery Identifies a Promising Treatment Strategy for an Aggressive Soft Tissue Cancer
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma
Research Shows AI Could Help More Breast Cancer Patients Receive the Right Treatment the First Time
From genomic testing to targeted treatment
How ProvSeq biomarker testing helped change this patient’s cancer journey
AI and Cancer treatment
The goal is to create a digital representation—or medical twin—of a patient and use advanced AI to understand what treatments work best and provide more informed options about the most effective paths
Spectrum News - St. Joe's - Cardio Genetics Testing
According to the cdc, heart disease is the leading cause of death in America. Going all the way back to the 1950's. and while people have become familiar with genetic testing for cancer risk.
Providence study finds AI ambient listening tool modestly reduces documentation burden, improves provider efficiency
Published in JAMA Network Open, a new Providence study uses real-world data to show how AI ambient listening reduces documentation burden, improving efficiency and clinician focus on patient care.
Providence to participate in federally funded research for early detection of a behavioral health crisis
Providence is joining a nationwide, federally funded research project to develop a Large Health Behavior Model.
Providence receives esteemed NIH grant for ‘paradigm shift’ in head and neck cancer treatments
Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.
New Providence study identifies provider-patient relationships as central to colorectal cancer screening disparities
A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.
New Prevention4ME Study: Access Matters More Than Outreach in Genetic Screening
Findings suggest that while outreach yields low engagement, low-cost methods such as email are feasible, and point-of-care access is critical for improving participation and equity. Health systems sho
Scaling insights into immunotherapy with GigaTIME
Researchers from Providence, the University of Washington, and Microsoft developed GigaTIME, a publicly available AI model that generates spatial proteomic images at scale.
Providence rolls out toolkit to boost cancer research equity
A research team from Renton, Wash based Providence has launched an interactive toolkit to help health systems boost equity in medical research.
Providence receives Pfizer-funded Conquer Cancer grant to use revolutionary AI tool to predict cancer mutations
Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients
